menu search

Biogen stock halted as it faces make-or-break moment for alzheimer's treatment

Biogen stock was halted Friday as a panel of experts to the FDA debated the merits of its Alzheimer's treatment, ...

June 9, 2023, 2:29 pm

Fda advisors to weigh whether alzheimer's drug leqembi should receive full approval

Medicare has promised to broadly cover leqembi, which costs $26,500 per year, if the FDA grants full ap...

June 9, 2023, 10:07 am

Fda panel to debate us approval for alzheimer's drug from eisai and biogen

A panel of experts on Friday will discuss whether to recommend traditional U.S. regulatory approval for Eisai and Biogen's new Alzheimer's drug ...

June 9, 2023, 7:04 am

Dow jones newswires: eisai shares rise as fda memo raises hopes for full approval of alzheimer’s drug

Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on leqe...

June 8, 2023, 2:00 am

Eisai shares rise as fda memo raises hopes for full approval of alzheimer's drug

Eisai shares 4523, +8.98% rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on ...

June 7, 2023, 10:00 pm

Fda staff say eisai's alzheimer's drug may get full approval despite concerns

Staff reviewers of the U.S. Food and Drug Administration (FDA) said on Wednesday that Eisai and Biogen's Alzheimer's drug, ...

June 7, 2023, 11:11 am

3 reasons to buy biogen stock (and 1 to sell)

Biogen has been struggling in recent years, but a couple of new products could help bolster its top line. The stock trades at a discount, which may be...

May 12, 2023, 10:15 am

Should you buy eli lilly stock now?

Eli Lilly announced the successful results of a phase 3 trial with donanemab, an experimental treatment for Alzheimer's disease. Treatment with the Al...

May 4, 2023, 5:13 am

Alzheimer's patients retain the benefits of leqembi even when they stop the drug, eisai says

Alzheimer's patients who take leqembi retain the benefits of the treatment even when they stop taking i...

April 6, 2023, 6:26 pm

Biogen (biib), eisai seek full nod for alzheimer drug leqembi

The FDA grants priority review to Biogen (BIIB) and Eisai's sBLA seeking traditional approval of Alzheimer's disease drug, ...

March 6, 2023, 9:47 am

Fda will review eisai's and biogen's alzheimer's treatment leqembi with decision on full approval expected in early july

Medicare has agreed to provide broader coverage once leqembi receives full FDA approval....

March 6, 2023, 9:27 am

Fda accepts eisai’s filing of a supplemental biologics license application and grants priority review for traditional approval of leqembi™ (lecanemab-irmb) for the treatment of alzheimer’s disease

Confirmatory Phase 3 Clarity AD data to be evaluated by FDA in determining whether to convert accelerated approval of ...

March 5, 2023, 11:30 pm

Maker of promising alzheimer's drug leqembi expects full fda approval this summer, expanded medicare coverage

Even if the FDA grants full approval of the Alzheimer's treatment leqembi, the rollout of the treatment...

February 17, 2023, 8:31 am

Alzheimer's drug leqembi: eisai u.s. president

Eisai U.S. President Ivan Cheung joins Yahoo Finance Live to discuss the latest news surrounding Alzheimer's treatment with ...

February 13, 2023, 5:19 pm

Approval for anavex's blarcamesine looks inevitable after biogen's leqembi approved

FDA grants emergency approval of Biogen/Eisai's leqembi (previously Lecanemab), based solely on Phase 2...

January 30, 2023, 12:13 pm

Lecanemab receives priority review status in japan

TOKYO and CAMBRIDGE, Mass., Jan. 29, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (N...

January 29, 2023, 11:30 pm

Why biogen's stock isn't soaring since its alzheimer's drug got approval

The Food and Drug Administration authorized leqembi under an accelerated approval pathway this month....

January 19, 2023, 9:20 am

Anavex: drug treatments for early alzheimer's disease

Anavex 2-73/blarcamesine at high concentrations in early Alzheimer's disease leads to improvements in cognition and activities of daily living that ar...

January 17, 2023, 5:10 pm

Should you buy biogen stock after its latest alzheimer's disease drug approval?

There's more to the story with Biogen after receiving good news for leqembi....

January 10, 2023, 5:55 am

Eisai files for full fda approval for alzheimer's drug leqembi

Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its...

January 6, 2023, 11:42 pm


Search within

Pages Search Results: